Rapid weight loss has been a hallmark of these medications, which work, in part, by making users feel full earlier by activating receptors of hormones secreted from the intestine (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) to reduce appetite and food intake
This is information we did not have before and it should be included in discussions between patients and their doctors, especially if patients have other known optic nerve problems like glaucoma or if there is preexisting significant visual loss from other causes." This study underscores the need for cautious use of semaglutide, particularly among patients at risk of eye conditions, and highlights the importance of ongoing research to fully understand the drug's implications
GLP-1 medications, the class that includes semaglutide, tirzepatide, and liraglutide, reduce hunger and slow digestion
Vaccines 20, 857880
This technique offers a subtle yet noticeable improvement, yielding fuller and smoother lips without requiring a full augmentation
Researchers Say the Findings Could Shape Future Healthcare Lead author Dr